Systemic & Neurological
Chronic Migraine
Chronic migraine can be disabling and resistant to standard treatments, driving patients to explore additional options.
Why regenerative therapy applies
We start with a thorough evaluation; regenerative and other therapies are discussed as part of a broader, individualized plan.
Are you a candidate?
Best after a careful workup and in coordination with headache care.
We turn patients away when the evidence says a therapy won't help. If a different path — or no treatment — serves you better, we'll say so at your consultation, before you've spent anything.
→Your options
Treatments we'd consider.
?Questions patients ask
Straight answers.
Can you help chronic migraine?
We evaluate carefully and discuss options as part of a broader plan. Regenerative approaches are investigational for migraine.
How much does treatment cost?
Stem cell therapy at Apex starts at $4,500 per joint (typically $4,500–$7,500); physician-performed PRP from $1,500; exosome therapy from $4,500. Stem cell protocols include PRP and a red light package in one inclusive fee. Your exact price is set at your free consultation, with HSA/FSA and financing available.
Is it covered by insurance?
No. U.S. insurers classify regenerative therapy for orthopedic and systemic conditions as investigational, so it is out of pocket. IV ketamine is usually self-pay. We keep care accessible with transparent pricing and financing.
Is it safe?
Serious adverse events are rare. The most common effects are temporary soreness or swelling for a few days. Every treatment is physician-performed under sterile, image-guided technique, and we screen candidacy carefully first.
Free consultation
Find out if you're a candidate.
A private consultation with Dr. Abdullah about your goals, your imaging, and your options — with an honest answer and a clear price. No obligation.
- Honest candidacy — we'll tell you if it won't help
- A clear, itemized price before you commit
- 0% financing · HSA / FSA accepted
Prefer to talk now? Call (972) 768-2328.
